VolitionRX Ltd. (VNRX)
Cameron Reynolds of VolitionRX Ltd. ($VNRX) sits down with Equities.com to discuss the company's blood-based diagnostic tests for cancer.
This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://www.equities.com/disclaimer.
- Spiro Rombotis, CEO of Cyclacel...
- Published on 06 December 2011
- Views (430)
- Equities.com sits down to talk with...
- Published on 08 November 2011
- Views (449)
- Steven Kriegsman of CytRx Corp talks...
- Published on 02 October 2013
- Views (388)
- Michael "Mickey" Fulp talks to...
- Published on 28 May 2013
- Views (542)